News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Recursion Pharmaceuticals
Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry
May 13, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results
May 09, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9
May 02, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion to Participate in Upcoming Investor Conferences
May 01, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Altitude Lab Secures Small Business Administration Growth Fund Accelerator Grant to Launch Horizon, a Commercialization Partnering Program
April 30, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion to Participate in Upcoming Investor Conference
April 02, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Publishes Annual Environmental, Social and Governance Report
March 26, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community
March 01, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion to Participate in Upcoming Investor Conferences
March 01, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results
February 27, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion to Host Public L(earnings) Call on February 27
February 20, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Altitude Lab Startups Raise Over $120M in Capital
January 24, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
January 08, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8
January 03, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry
December 20, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Bayer and Recursion Focus Research Collaboration on Oncology
November 09, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results
November 09, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion to Participate in Upcoming Investor Conference
November 02, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion to Participate in Upcoming Investor Conferences
September 05, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection
September 05, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds
August 08, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results
August 08, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion to Participate in Upcoming Investor Conference
August 01, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships
July 26, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery
July 12, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem
June 26, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled
June 13, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion to Participate in Upcoming Investor Conferences
June 01, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer
May 16, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Recursion Provides Business Updates and Reports First Quarter 2023 Financial Results
May 08, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Tickers
RXRX
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.